Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden

被引：0
|
作者：
Bellmunt, Joaquim
Powles, Thomas
Park, Se Hoon
Voog, Eric
Valderrama, Begona Perez
Gurney, Howard
Ullen, Anders
Loriot, Yohann
Sridhar, Srikala S.
Tsuchiya, Norihiko
Sternberg, Cora N.
Aragon-Ching, Jeanny B.
Petrylak, Daniel P.
Duran, Miguel A. Climent
Tyroller, Karin
Hoffman, Jason
Jacob, Natalia
Grivas, Petros
Gupta, Shilpa
机构：
[1] Beth Israel Deaconess Med Ctr, New York, NY USA
[2] Harvard Med Sch, Boston, MA USA
[3] Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, England
[4] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[5] Ctr Jean Bernard, Clin Victor Hugo, Le Mans, France
[6] Hosp Univ Virgen Rocio, Seville, Spain
[7] Macquarie Univ, Dept Clin Med, Westmead, NSW, Australia
[8] Karolinska Univ Hosp, Solna, Sweden
[9] Univ Paris Saclay, INSERMU981, Gustave Roussy, Villejuif, France
[10] Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON, Canada
[11] Yamagata Univ, Fac Med, Yamagata, Japan
[12] Englander Inst Precis Med, Meyer Canc Ctr, New York, NY USA
[13] Inova Schar Canc Inst, Fairfax, VA USA
[14] Yale Canc Ctr, New Haven, CT USA
[15] Inst Valenciano Oncol, Valencia, Spain
[16] EMD Serono, Billerica, MA USA
[17] Healthcare Business Merck KGaA, Darmstadt, Germany
[18] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
[19] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4566
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term patient-reported outcomes (PROs) in the phase 3 JAVELIN Bladder 100 trial
    Grivas, Petros
    Aragon-Ching, Jeanny B.
    Bellmunt, Joaquim
    Loriot, Yohann
    Sridhar, Srikala S.
    Su, Po-Jung
    Park, Se Hoon
    Yamamoto, Yoshiaki
    Jacob, Natalia
    Hoffman, Jason
    Kearney, Mairead
    Schlichting, Michael
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 581 - 581
  • [2] Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts)
    Gupta, S.
    Climent Duran, M. A.
    Sridhar, S.
    Powles, T. B.
    Bellmunt, J.
    Tyroller, K.
    Guenther, S.
    di Pietro, A.
    Grivas, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S1207 - S1207
  • [3] Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in patients (pts) with histological subtypes
    Loriot, Yohann
    Gupta, Shilpa
    Powles, Thomas
    Grivas, Petros
    Petrylak, Daniel P.
    Tyroller, Karin
    Jacob, Natalia
    Hoffman, Jason
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients
    Gupta, S.
    Duran, M. A. Climent
    Sridhar, S. S.
    Powles, T.
    Bellmunt, J.
    Park, S. H.
    Gurney, H.
    Tsuchiya, N.
    Petrylak, D. P.
    Tomita, Y.
    di Pietro, A.
    Manitz, J.
    Tyroller, K.
    Hoffman, J.
    Jacob, N.
    Grivas, P.
    ESMO OPEN, 2025, 10 (04)
  • [5] Long-term safety of avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC) in the JAVELIN Bladder 100 trial.
    Bellmunt, Joaquim
    Aragon-Ching, Jeanny B.
    Climent, Miguel Angel
    Sridhar, Srikala S.
    Powles, Thomas
    Cislo, Paul
    Michelon, Elisabete
    Di Pietro, Alessandra
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in patients (pts) with high body mass index (BMI)
    Aragon-Ching, Jeanny B.
    Petrylak, Daniel P.
    Sridhar, Srikala S.
    Gupta, Shilpa
    Grivas, Petros
    Powles, Thomas
    Gurney, Howard
    Jacob, Natalia
    Tyroller, Karin
    Guenther, Silke
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 600 - 600
  • [7] Avelumab first-line (1 L) maintenance for advanced urothelial carcinoma (aUC): long-term outcomes from JAVELIN Bladder 100 in subgroups defined by response to 1 L chemotherapy
    Valderrama, Begona P.
    Powles, Thomas
    Sridhar, Srikala S.
    Caserta, Claudia
    Loriot, Yohann
    Gupta, Shilpa
    Bellmunt, Joaquim
    Sternberg, Cora N.
    Pook, David W.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert J.
    di Pietro, Alessandra
    Park, Se Hoon
    Grivas, Petros
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 139 - 139
  • [8] Avelumab first-line (1L) maintenance in advanced urothelial carcinoma (aUC): Conditional survival and long-term safety in patients (pts) treated for ≥1 or ≥2 years in JAVELIN Bladder 100
    Grivas, P.
    Park, S. H.
    Voog, E.
    Su, W-P.
    Demey, W.
    Fong, P. C.
    Garcia, J. A.
    Jacob, N.
    Gerhold-Ay, A.
    Tyroller, K.
    Hoffman, J.
    Bellmunt, J.
    Powles, T. B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1144 - S1144
  • [9] Avelumab first-line (1 L) maintenance for advanced urothelial carcinoma (aUC): Results from patients with ≥12 months of treatment in JAVELIN Bladder 100
    Aragon-Ching, Jeanny B.
    Grivas, Petros
    Loriot, Yohann
    Bellmunt, Joaquim
    Pook, David W.
    Wang, Jing
    Michelon, Elisabete
    di Pietro, Alessandra
    Powles, Thomas
    Sridhar, Srikala S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 138 - 139
  • [10] AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM FOLLOW-UP RESULTS FROM THE JAVELIN BLADDER 100 TRIAL
    Grivas, Petros
    Bellmunt, Joaquim
    Park, Se Hoon
    Voog, Eric
    Mans, Le
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Sternberg, Cora N.
    Aragon-Ching, Jeanny B.
    Petrylak, Daniel P.
    Blake-Haskins, John A.
    Laliberte, Robert J.
    Wang, Jing
    Costa, Nuno
    Powles, Thomas
    JOURNAL OF UROLOGY, 2022, 207 (05): : E183 - E183
12345